[HTML][HTML] The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan

S Yandrapalli, WS Aronow, P Mondal… - Archives of Medical …, 2017 - ncbi.nlm.nih.gov
… of carperitide is used as a treatment for acute decompensated heart failure in Japan without
… Von Lueder et al. randomized post-myocardial infarction adult male Sprague-Dawley rats to …

The safety of sacubitril-valsartan for the treatment of chronic heart failure

JM Tyler, JR Teerlink - Expert Opinion on Drug Safety, 2017 - Taylor & Francis
… ) of patients hospitalized for acute decompensated heart failure and the PARADISE-HF trial
(NCT02924727) of post-myocardial infarction patients … To learn about our use of cookies and …

Sacubitril/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR‐181a in a rodent chronic myocardial infarction …

E Vaskova, G Ikeda, Y Tada, C Wahlquist… - … of the American Heart …, 2020 - Am Heart Assoc
Heart failure (HF) is the leading cause of hospital admission … function and remodeling, we
used a chronic HF model post … to enhance the cardiovascular function post myocardial injury. …

[引用][C] Clinical Effects of Sacubitril/Valsartan Combined with Dapagliflozin in Patients with Diabetes and ST-segment Elevation Myocardial Infarction

Z Wang, Z Li, Y Hou, P Wang, Z Zhao… - Cardiovascular …, 2023 - Compuscript

Effect of sacubitril/valsartan on the prognosis of patients with heart failure with midrange ejection fraction

Z Yongyue, XU Zhaolong - J Clin Cardiol, 2021 - lcmwen.whuhzzs.com
… of prognosis of sacubitril/valsartan in the patients with heart failure with midrange ejection
fraction… The control group used conventional heart failure treatment(including the application of …

Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure

N Phreaner, BH Greenberg - Current Emergency and Hospital Medicine …, 2017 - Springer
… /valsartan is a safe and efficacious treatment for heart failureuse of sacubitril/valsartan in
heart failure with preserved ejection fraction and in post-myocardial infarction left ventricular

Cost-effectiveness analysis of sacubitril/valsartan in chronic heart failure with reduced ejection fraction in Spain

C Lacasa, M Obradors, M Figueras… - Value in …, 2016 - valueinhealthjournal.com
… performed (below the commonly used threshold in Spain of 30,000€ /… patients. The aim of
this study was to evaluate the value and structure of treatment cost of post myocardial infarction

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies

S Frantz, MJ Hundertmark… - European heart …, 2022 - academic.oup.com
… be used to stratify individuals at risk for remodelling, a patient … In PROVE-HF, sacubitril/valsartan
in HFrEF patients led to … in patients at risk for heart failure after myocardial infarction in …

[HTML][HTML] Targeted imaging of angiogenesis post-myocardial infarction predicts development of heart failure

AJ Sinusas - Journal of Nuclear Cardiology, 2023 - Springer
… In another rat MI study, sacubitril/valsartan was shown to induce an uptake of 99m Tc-… was
used in a pilot clinical SPECT imaging studies in nine patients with heart failure who had been …

To Evaluate the'Real World'Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.

K Sharma, H Desai, N Sharm, M Laddha… - The Journal of the …, 2022 - europepmc.org
heart failure and are well studied in Acute Coronary Syndromes (ACS). There is paucity of
data of Bisoprolol in acute ICU setting in patients admitted with left ventricular … we use a word-…